[1]
Gouni-Berthold I, Berthold HK. Current options for the pharmacotherapy of obesity. Curr Pharm Des 2019; 25(18): 2019-32.
[2]
Radak D, Tanaskovic S, Neskovic M. The obesity-associated risk in open and endovascular repair of abdominal aortic aneurysm. Curr Pharm Des 2019; 25(18): 2033-7.
[3]
Cӑtoi AF, Vodnar DC, Corina A, et al. Gut microbiota, obesity and bariatric surgery: Current knowledge and future perspectives. Curr Pharm Des 2019; 25(18): 2038-50.
[4]
Katsiki N, Anagnostis P, Kotsa K, Goulis DG, Mikhailidis DP. Current options for the pharmacotherapy of obesity. Curr Pharm Des 2019; 25(18): 2051-9.
[5]
Tan Y, Chen S, Zhong J, Ren J, Dong M. Mitochondrial injury and targeted intervention in septic Cardiomyopathy. Curr Pharm Des 2019; 25(18): 2060-70.
Current Pharmaceutical Design
Title:Clinical Approach for the Treatment of Obesity-associated Diseases
Volume: 25 Issue: 18
Author(s): Esma R. Isenovic
Affiliation:
Export Options
About this article
Cite this article as:
Isenovic R. Esma , Clinical Approach for the Treatment of Obesity-associated Diseases , Current Pharmaceutical Design 2019; 25 (18) . https://dx.doi.org/10.2174/138161282518190822153931
DOI https://dx.doi.org/10.2174/138161282518190822153931 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
33
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tracking the Mesenchymal Stem Cell Fate After Transplantation Into the Infarcted Myocardium
Current Stem Cell Research & Therapy New Perspectives on Acetaminophen
Current Cardiology Reviews Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth
Current Drug Targets miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery
MicroRNA The Many Antithrombotic Actions of Nitric Oxide
Current Drug Targets Epigenetics in the Cerebrovascular System: Changing the Code without Altering the Sequence
Current Neurovascular Research Editorial: Overview on microRNAs in Cancer Development and Virus Infection
MicroRNA The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Patented Biotechnological Applications of Serpin: an Update
Recent Patents on DNA & Gene Sequences Ventricular and Vascular Stiffening in Aging and Hypertension
Current Hypertension Reviews Porphyrin-Photosensitized Processes: Their Applications in the Prevention of Arterial Restenosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design A Giant Internal Iliac Artery Aneurysm with Arteriovenous Fistulization
Current Medical Imaging New Devices for Treating Acute Ischemic Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets The Rabbit as an Experimental and Production Animal: From Genomics to Proteomics
Current Protein & Peptide Science Review: Technegas - 99mTc-Metal Core Graphite Nanoparticles for Pulmonary Ventilation Imaging
Current Radiopharmaceuticals Crosstalk between Oxidative and Nitrosative Stress and Arterial Stiffness
Current Vascular Pharmacology A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery